CPhI Worldwide Entries for 15th Annual Pharma Awards Now Open
CPhI Worldwide-organized by UBM (part of Informa PLC)-announced the award entries for the 2018 CPhI Pharma Awards. The industry’s awards return for a 15th edition, with 17 categories honoring companies and individuals driving the pharma industry forward through innovations, technologies, and strategies.
Categories include innovations across APIs, excipients, and formulations to drug delivery technologies, packaging, patient-centricity, contract services, and business performance focused awards.
This year the Bioprocessing & Manufacturing category-powered by the new bioLIVE event-is expected to see an increase in applications in light of the increased biologics and supply chain audiences now attending CPhI Worldwide. Among 2017’s most hotly contested categories were API Development, along with the fiercely competitive ‘Product Packaging’ and ‘Drug Delivery and Devices’ categories. Another increasingly significant category is the Corporate Social Responsibility award.
Submitting your entry(ies) for the CPhI Pharma Awards is free of charge and the deadline is July 31st 2018-with shortlisted finalists announced August 28th, 2018. The winners will be unveiled during a ceremony at the Eurostars Madrid Tower in Madrid, on October 9th during the evening of the first day of CPhI Worldwide.
To apply please visit https://awards.cphi.com
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
Talphera Cuts NEPHRO CRRT Study Size, Secures $14.8 Million Private Placement
April 1st 2025The trial size adjustment, along with protocol modifications and the addition of higher-enrollment sites, is expected to facilitate completion of the NEPHRO CRRT study of Niyad in patients undergoing renal replacement therapy by the end of 2025.
